Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Integrating genomic, transcriptomic, and phenotypic information to explore drug resistance in Mycobacterium tuberculosis sub-lineage 4.2.2.2

Journal of Applied Microbiology(2025)10.1093/jambio/lxaf063Source: DataRank Database

Integrating genomic, transcriptomic, and phenotypic information to explore drug resistance in Mycobacterium tuberculosis sub-lineage 4.2.2.2 is a research paper published in Journal of Applied Microbiology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.76)OA: hybridTopics (50)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Abaysew Ayele,Tesfaye Gelanew ORCID,Abay Atnafu ORCID,Michael J. Brennan ORCID,Melaku Tilahun ORCID

Live enrichment

PubMed:40074543 PMC:PMC11940716 OpenAlex:https://openalex.org/W4408348944

National Institutes of Health

Grant: #H3A-18–003

NIH HHS

Grant: #H3A-18-003

FIC NIH HHS

Grant: D43 TW009127

Wellcome Trust

FWCI

0.76

Citation Percentile

0.7%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1093/jambio/lxaf063

publisherhttps://doi.org/10.1093/jambio/lxaf063

publisherhttps://academic.oup.com/jambio/advance-article-pdf/doi/10.1093/jambio/lxaf063/62387997/lxaf063.pdf

publisherhttps://academic.oup.com/jambio/article-pdf/136/3/lxaf063/62387997/lxaf063.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40074543

Fields of Study

Tuberculosis Research and EpidemiologyMycobacterium research and diagnosisDiagnosis and treatment of tuberculosisMycobacterium tuberculosisAntitubercular AgentsHumansMicrobial Sensitivity TestsPhenotypeGenomicsTranscriptomeGene Expression ProfilingBacterial ProteinsTuberculosis, Multidrug-ResistantEthiopiaGenome, BacterialDrug Resistance, BacterialDrug Resistance, Multiple, Bacterial

MeSH Terms

Antitubercular AgentsBacterial ProteinsEthiopiaHumansMicrobial Sensitivity TestsMutationMycobacterium tuberculosisPhenotypeRifampinGenome, BacterialTuberculosis, Multidrug-ResistantGene Expression ProfilingGenomicsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialTranscriptome

Keywords

BiologyDrug resistancerpoBPhenotypeMycobacterium tuberculosisTranscriptomeGeneticsGeneTuberculosisGene expression profilingGene expressionMedicineDrug-resistanceLineageEthiopiaRnaseqDiscordance

Sustainable Development Goals

SDG 0: Good health and well-being

Integrating genomic, transcriptomic, and phenotypic information to explore drug resistance in Mycobacterium tuberculosis sub-lineage 4.2.2.2

FAIR Checklist

Authors (15)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)